Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-10

Clinical Trial Update: Dexamethasone for the Prevention of Postoperative Cognitive Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dexamethasone for prevention of postoperative cognitive dysfunction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University of Sao Paulo | Conditions: Postoperative Cognitive Dysfunction | Phase 4 | Status: COMPLETED